Digital Sponsored The content velocity trap: Why producing more is making your... Viseven explores how to fix the broken upstream engagement strategy process without losing even more time, resources, and effort in the process.
Oncology What will ASCO 2026 reveal about oncology innovation’s new g... The next leaders in oncology will be the ones built to adapt in real time.
Market Access What rare disease commercialisation in Europe teaches us - a... Rare disease launches are the ultimate stress test for European commercialisation.
Sales & Marketing Sponsored Company Profile – POA Pharma In a landscape shaped by regulatory complexity, POA Pharma is demonstrating that smart, regionally tailored growth can outperform scale.
Market Access Why impactful and scalable global Medical Information (MI) p... A trusted MI partner ensures compliance with global and local regulations and provides consistent access to accurate medical information.
Digital Sovereign AI as the backbone of LSHC GCC innovation: Priorit... In recent times, Global Capability Centres (GCCs) have become drivers of innovation for global Life Sciences and Healthcare (LSHC) companies.
Patients ASCO 2026: Quality of life, not just quantity, with Dr Harol... Dr Harold Keer, chief medical officer at Taiho Oncology, goes in-depth about why his company places such an emphasis on oral formulations.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.